Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,783,546 Compounds
The present invention relates to novel compounds that inhibit Lp-PLA.sub.2 activity, processes for their preparation, to compositions containing them and to...
US-9,783,545 Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with...
Compounds, compositions and methods for the treatment of retinal degenerative diseases, such as retinitis pigmentosa, Leber's congenital Amaurosis, Syndromic...
US-9,783,544 CXCR7 antagonists
Compounds having formula I, ##STR00001## or pharmaceutically acceptable salts, hydrates or N-oxides thereof are provided and are useful for binding to CXCR7,...
US-9,783,543 Aminoimidazopyridazines
The present invention relates to amino-substituted imidazopyridazine compounds of general formula (I), in which A, R1, R2, R3, R4 and n are as defined in the...
US-9,783,542 Process for pralatrexate
The present invention provides a novel process for the purification of alpha-propargylhomoterephthalic acid dimethyl ester substantially free of ...
US-9,783,541 5'-nucleotidase inhibitors and therapeutic uses thereof
The subject matter of the present invention is compounds which have a 6-aminopurine backbone corresponding to formula (I): in which R.sub.1, R.sub.2, R.sub.3,...
US-9,783,540 Substituted tetrahydropyrans as CCR2 modulators
Compounds are provided that are modulators of the CCR2 receptor. The compounds have the general formula (I): ##STR00001## and are useful in pharmaceutical...
US-9,783,539 Indoloquinolone compounds as anaplastic lymphoma kinase (ALK) inhibitors
Disclosed herein are certain indoloquinolone compounds, methods of preparation thereof, pharmaceutical compositions thereof, and uses thereof, such as their...
US-9,783,538 Bicyclic heterocycle compounds and their uses in therapy
The invention relates to new bicyclic heterocycle compounds, to pharmaceutical compositions comprising the compounds and to the use of the compounds in the...
US-9,783,537 3-(4-ethylnylphenyl) pyridopyrimidinone compounds and process for preparation thereof useful as potential...
The present invention provides 3-(4-ethynylphenyl) pyridopyrimidinone compounds of formula A active as potential anticancer agents. The 3-(4-ethynylphenyl)...
US-9,783,536 Nitrogen-containing heterocyclic compound or salt thereof
A compound represented by Formula [1](in the formula, Z.sup.1 represents N, CH, or the like; X.sup.1 represents NH or the like; R.sup.1 represents a heteroaryl...
US-9,783,535 Substituted noribogaine
This invention relates noribogaine derivatives, compositions and methods of use thereof.
US-9,783,534 Crystalline form of 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-y- l)-1,...
The present invention relates to a novel crystalline form of 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-y- ...
US-9,783,533 Glutaminase inhibitors
The present disclosure provides compounds of formula (I) to (III) as glutaminase inhibitors, methods of preparing them, pharmaceutical compositions containing...
US-9,783,532 Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
This disclosure relates to the field of molecules having pesticidal utility against pests in phyla Nematoda, Arthropoda, and/or Mollusca, processes to produce...
US-9,783,531 Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
The invention provides certain thiazole-substituted aminoheteroaryl compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein R.sup.1,...
US-9,783,530 Factor Xla inhibitors
The present invention provides a compound of Formula I (The chemical formula should be inserted here.) and pharmaceutical compositions comprising one or more...
US-9,783,529 Pyridazinone compounds and methods for the treatment of cystic fibrosis
The invention relates to a compound of having the following formulae and methods of treating cystic fibrosis: ##STR00001##
US-9,783,528 Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase
This invention relates to novel inhibitors of UDP-glucose: N-acyl-sphingosine glucosyltransferase and pharmaceutically acceptable salts thereof. This invention...
US-9,783,526 Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics
The present invention relates to oligooxopiperazines that mimic helix .alpha.B of the C-terminal transactivation domain of HIF-1.alpha.. Also disclosed are...
US-9,783,525 Map kinase modulators and uses thereof
The invention provides for novel MAP kinase inhibitors and compositions comprising the same. In some embodiments, the MAP kinase inhibitors are p38.alpha. MAP...
US-9,783,524 Protein tyrosine kinase modulators and methods of use
Heterocyclic pyrimidine compounds that modulate mutant-selective epidermal growth factor receptor (EGFR) and ALK kinase activity are disclosed. More...
US-9,783,523 N-acylimino heterocyclic compounds
The present invention relates to N-acylimino compound of formula (I): ##STR00001## wherein X is O or S, in particular O; Y is a single bond, O, S or NR.sup.5;...
US-9,783,522 2-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereof
Provided is a compound superior in an autotaxin inhibitory action and the like, effective as a prophylactic or therapeutic drug for diseases involving ATX. The...
US-9,783,521 PDE10 inhibitors and related compositions and methods
Compounds that inhibit PDE10 are disclosed that have utility in the treatment of a variety of conditions, including (but not limited to) psychotic, anxiety,...
US-9,783,520 Macrocyclic compounds, polymers, and methods for making same
The application relates to macrocyclic compounds and related polymers, as well as to processes for synthesizing them, e.g., using olefins as starting material.
US-9,783,519 Palladium/silver co-catalyzed tandem reactions synthesis of phenylacetophenone derivatives by...
This invention relates to the quick and efficient synthesis of anti-tumor or anti-cancer compounds. More particularly, it relates to the quick and efficient...
US-9,783,518 Therapeutic agent and treatment method for ameliorating uremia
A therapeutic agent and a treatment method for uremia of human and animals, which therapeutic agent can be easily taken, has lower side effects, and which is...
US-9,783,517 Method for synthesis of an output including diesters of 5-methyl-2-furoic acid
The present invention describes methods and apparatuses for the synthesis of 5-(chloromethyl)-2-furaldehyde (CMF) from saccharides in pure or crude form, the...
US-9,783,516 Reduction of HMF ethers with metal catalyst
Methods of making reduced derivatives of hydroxymethyl furfural using metal catalysts are described. The derivatives may have tetrahydrofuran or furan nucleus...
US-9,783,515 Radiomitigating pharmaceutical formulations
The present disclosure relates to compounds of Formula (I) and (II), compositions containing the compounds (alone or in combination with other agents), and...
US-9,783,514 Method for preparing methylated amines
The present invention relates to a method for preparing methylated amines using carbon dioxide and to the use of the method for manufacturing vitamins,...
US-9,783,513 STAT3 inhibitors and their anticancer use
In one aspect, the invention relates to substituted 6-amino-5,8-dioxo-5,8-dihydronaphthalene-1-sulfonamide analogs and derivatives thereof, substituted ...
US-9,783,512 Bicyclic methylene aziridines and reactions thereof
The oxidative functionalization of olefins is a common method for the formation of vicinal carbon-heteroatom bonds. However, oxidative methods to transform...
US-9,783,511 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the...
The invention provides certain benzoxazine compounds of the Formula (I) or pharmaceutically acceptable salts thereof wherein R.sup.1, R.sup.2, R.sup.a1,...
US-9,783,510 Small molecule mediated transcriptional induction of E-cadherin
In one aspect, the invention relates to N-acetamidoalkyl-5-arylisoxazole-3-carboxamide analogs, derivatives thereof, and related compounds, which are useful as...
US-9,783,509 Six-membered C-N-linked aryl sulfide derivatives and aryl sulfoxide derivatives as pest conrol agents
The present invention relates to novel heterocyclic compounds, to processes for preparation thereof and to the use thereof for controlling animal pests, which...
US-9,783,508 Process for the manufacture of isavuconazole or ravuconazole
The invention relates to a process for the manufacture of diastereomerically and enantiomerically enriched triazole compounds isavuconazole and ravuconazole,...
US-9,783,507 Neprilysin inhibitors
In one aspect, the invention relates to compounds having the formula I: ##STR00001## where R.sup.1-R.sup.6 are as defined in the specification, or a...
US-9,783,506 Process for the large scale production of 1H-[1,2,3]triazole and its intermediate 1-benzyl-1H-[1,2,3]triazole
The present invention provides a process for the large scale production of 1H-[1,2,3]triazole of formula (I) and its intermediate 1-benzyl-1H-[1,2,3]triazole of...
US-9,783,505 Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
Provided herein are diaminopyrimidyl Compounds having the following structures: ##STR00001## wherein X, L, R.sup.1, and R.sup.2 are as defined herein,...
US-9,783,504 Kinase inhibitors for the treatment of disease
The invention relates to compounds and their use in the treatment of disease. Novel irreversible inhibitors of wild-type and mutant forms of EGFR, FGFR, ALK,...
US-9,783,503 Crystalline forms of an estrogen receptor modulator
Described herein are amorphous and crystalline forms of pharmaceutically acceptable salts of the estrogen receptor modulator ...
US-9,783,502 Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-HT.sub.2A...
The present invention relates to processes for preparing phenyl-pyrazoles of Formula (I) and salts and pharmaceutical compositions thereof, useful as modulators...
US-9,783,501 Substituted quinolines as modulators of sodium channels
The invention relates to compounds of formula I or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels: ##STR00001## The...
US-9,783,500 2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition
Various 2-aminoquinoline compounds as can be used, in vivo or in vitro, for selective inhibition of neuronal nitric oxide synthase.
US-9,783,499 Quinoline derivatives and their applications
The invention relates to a series of quinoline derivatives of general formula I, pharmaceutically acceptable salts, hydrates, solvates or prodrugs. Thereof M,...
US-9,783,498 Process for preparing the anti-tumor agent ...
The present invention relates a new process to synthesize 6-(7-((1-aminocyclo-propyl)-methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-- 1-naphthamide (AL3810) by...
US-9,783,497 Determining degradation of 3,4-diaminopyridine
The present invention relates to methods of determining the purity of a sample of 3,4-diaminopyridine comprising determining the presence, absence, or amount of...
US-9,783,496 Oxindole compounds, solvent-free synthesis and use thereof
The present invention discloses oxindole compounds and a single step, one pot reaction for the synthesis of oxindole derivates via a solvent free Passerini...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.